Prime Therapeutics
Andrew Numedahl is a seasoned financial professional with extensive experience in pricing analysis and financial management. Currently serving as a Senior Pricing Analyst at Prime Therapeutics since May 2022, Andrew previously held prominent roles including Senior Financial Analyst at PreferredOne from May 2014 to June 2022, and Senior Revenue Accountant at UnitedHealthcare from December 2008 to May 2014. Andrew began their career as a Staff Accountant at Carlson Companies in 2008. Andrew holds a degree from Luther College, where studies were completed from 2003 to 2007.
Prime Therapeutics
31 followers
Manages pharmacy benefits for health plans, employers and government programs, including Medicare and Medicaid. It also processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions.